Published

The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Neuropharmacology
Date: 2018-11-01
Source: PubMed
DOI: 10.1016/j.neuropharm.2018.05.012
PubMed: 29753748

Authors

Johnson MW Griffiths RR Hendricks PS Henningfield JE

Watch author

Derived topics and classifications

psilocybin Depression Anxiety Addiction Receptor Pharmacology Review Article Cancer Patients Safety Review Article

Citation graph

0 referenced DOIs found in stored source metadata. 9 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Quantifying psilocybin exposure in a natural product-based retreat setting: An observational field method for dose measurement2026-12-01 Genome-based optimization of psilocybin and N,N-dimethyltryptamine biosynthetic pathways in E. coli using CRISPR-associated transposases2026-09-01 Learnings from a hybrid communities of practice group therapy model to support psilocybin-assisted therapy for patients with a terminal diagnosis2026-07-20 Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical Development2026-07-03 Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of Care2026-05-14 Prevalence and Correlates of Past-Year Psilocybin Use in the U.S., 2024, USA2026-05-01 Psilocybin use in Puerto Rico: Patterns, motivations, and personality correlates from an online survey2026-04-15 Psilocin alleviates acute itch in mice: possible involvement of 5-HT2A receptors and kynurenine pathway2025-10-01 The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act.2018-11-01

Related papers

Psilocybin may help cancer patients with depression and anxiety for yearsAccess Science · 2020-01-01 The Utility of Psilocybin in Managing Anxiety and Depression in Cancer PatientsBiochemistry and Molecular Biology Education · 2018-08-01 LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders: a Randomized, Double-blind, Placebo-controlled Phase II StudyClinicalTrials.gov · 2021-12-22